Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Rigshospitalet, Denmark | OTHER |
| Region of Southern Denmark | OTHER |
| Danish Cancer Society | OTHER |
| Novo Nordisk A/S |
Not provided
Not provided
Not provided
Not provided
Not provided
This qualitative study explores the lived experience of high-grade glioma patients and their close relatives at time of recurrence. With focus on the decision-making about treatment and care..
High-Grade Glioma is a life-threatening disease that can cause the patient substantial physical, mentally and psychosocially impairment. The life expectancy is short, and a majority of patients experience recurrence of tumour growth. At time of recurrence, the treatment possibilities can include surgery, oncological treatment and/or palliative care.
In this situation the patients and their close relatives need to make a difficult balancing between benefits and trade offs.
Little is known about how the patients and their close relatives experience the recurrence and the decision-making process.
The objective of this study is therefore to explore the perspectives, experiences and needs in patients and their close relatives in relation to the decision-making process at time of recurrence.
Data will be generated through semi-structured interviews. Interviews will be analysed and interpreted using a Ricoeur inspired method of qualitative analysis.
The study is part of a larger PhD-study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients | Patients with recurrent high-grade glioma | ||
| Relatives | Close relatives of patients with recurrent high-grade glioma |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Experiences of patients and relatives | How patients and their close relatives experience the decision-making process | Interviews are performed 2-6 weeks after the decision-making |
| Involvement preferences | The preferences of patients and relatives for being involved in the decision-making. | Interviews are performed 2-6 weeks after the decision-making |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Two study populations:
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Frantz Rom Poulsen, Professor | Department of Neurosurgery Odense University Hospital DK-5000 Odense C DENMARK | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Copenhagen University Hospital; Rigshospitalet | Copenhagen | Denmark | ||||
| Odense University Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005910 | Glioma |
| D010358 | Patient Participation |
| ID | Term |
|---|---|
| D018302 | Neoplasms, Neuroepithelial |
| D017599 | Neuroectodermal Tumors |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D009370 | Neoplasms by Histologic Type |
Not provided
Not provided
| INDUSTRY |
Not provided
Not provided
Not provided
| Odense |
| Denmark |
| D009369 | Neoplasms |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009380 | Neoplasms, Nerve Tissue |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |